1
|
Fujita N, Hatakeyama S, Momota M, Okamoto T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. An optimized surveillance protocol based on the European Association of Urology substratification improves surveillance costs after transurethral resection of bladder tumor in patients with high-risk non-muscle-invasive bladder cancer. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00323-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
2
|
Momota M, Fujita N, Ishida M, Iwane T, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Yamaya K, Ohyama C. Can erectile dysfunction severity predict major adverse cardiovascular events in men undergoing dialysis: A prospective cohort study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00605-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
3
|
Fujita N, Momota M, Horiguchi H, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C. High aortic calcification burden is a risk factor for acute kidney injury in patients who undergoing radical cystectomy: A multi-institutional retrospective cohort study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00198-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
4
|
Fujita N, Momota M, Soma O, Noro D, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Elevated prothrombin fragment 1+2 predicts severe acute kidney injury in patients with urological sepsis. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00192-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
5
|
Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Iwamura H, Okamoto T, Yoneyama T, Sato S, Ohyama C. Outcomes comparison between the robot-assisted radical prostatectomy with extended pelvic lymph node dissection and neoadjuvant chemohormonal therapy without extended pelvic lymph node dissection in patients with organ confined high-risk prostate cancer. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00909-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
6
|
Hatakeyama S, Tanaka T, Noro D, Okamoto T, Narita T, Ishi N, Tanaka R, Oishi T, Miura H, Ohyama C. Impact of disease status heterogeneity of the STAMPEDE trial arm J population on oncological outcomes in high-risk nonmetastatic prostate cancer. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01249-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus J, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C. Clinical significance of α2,3-sialylated prostate-specific antigen density and MRI for high-grade prostate cancer in biopsy-naïve men with elevated PSA level. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00565-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
8
|
Iwamura H, Yoneyama T, Kodama H, Ozaki K, Ozaki Y, Okita K, Konishi S, Narita T, Fujita N, Kojima Y, Okamoto T, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C. Development of a novel diagnostic model for urological cancers using comprehensive N-glycan signatures of serum immunoglobulins with a machine learning approach. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00097-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Anan G, Yoneyama T, Noro D, Tobisawa Y, Hatakeyama S, Yoneyama M, Yamamoto H, Yoneyama T, Hashimoto Y, Sato M, Ohyama C. Identification of aberrant glycosylation of osteopontin on urinary stone formation. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00614-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Narita T, Hatakeyama S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ohyama C. Preoperative frailty promotes sarcopenia after radical cystectomy in patients with muscle-invasive bladder cancer. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34135-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
11
|
Yoneyama T, Tobisawa Y, Kaneko T, Kaya T, Hatakeyama S, Mori K, Sutoh Yoneyama M, Okubo T, Mitsuzuka K, Duivenvoorden W, Pinthus J, Hashimoto Y, Ito A, Koie T, Gardiner R, Ohyama C. Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32909-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
12
|
Horiguchi H, Hatakeyama S, Hashimoto Y, Yoneyama T, Yamamoto H, Imai A, Ohyama C. Impact of neoadjuvant chemotherapy on Ki67 proliferation index and PDL1 expression in muscle-invasive bladder cancer. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32678-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
13
|
Horiguchi H, Kubota Y, Hatakeyama S, Yoneyama T, Hashimoto Y, Itou H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C. Trends in the utilizaton of platinum-based neoadjuvant chemotherapy for upper tract urothelial carcinoma. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32776-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
14
|
Narita T, Hatakeyama S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ohyama C. Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 5 years after ileal neobladder construction. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34134-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
15
|
Narita T, Hatakeyama S, Imai A, Tanaka T, Hamano I, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Nakaji S, Suzuki T, Ohyama C. The impact of malnutrition on the risk of developing urolithiasis. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33387-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
16
|
Yamamoto H, Yoneyama T, Hamano I, Tobisawa Y, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yamaguchi Y, Ohyama C. Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32896-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
17
|
Hatakeyama S, Konishi S, Okita K, Soma O, Matsumoto T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C. The gap of frailty value from a community-dwelling population predict oncological outcomes in patients with urological cancers. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy435.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Hatakeyama S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C. The relationship between preoperative stage IIIB chronic kidney disease and post-surgical oncological outcomes in patients with urothelial carcinoma. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy435.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C. Comparison between robot-assisted radical prostatectomy and minimum incision endoscopic radical prostatectomy for high-risk prostate cancer following neoadjuvant therapy: A propensity score-matched analysis. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy434.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Hatakeyama S, Kodama H, Konishi S, Okita K, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C. Does neoadjuvant chemotherapy promote chemoresistance after recurrence in patients with muscle-invasive bladder cancer? Ann Oncol 2018. [DOI: 10.1093/annonc/mdy435.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
21
|
Hashimoto Y, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C. Aldo-keto-reductase 1C3 expression in prostate cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy434.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Fujita N, Hatakeyama S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C. 295 The implication of aortic calcification on severe erectile dysfunction in patients with end stage renal disease. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Fujita N, Hatakeyama S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C. 414 The implication of aortic calcification on late onset hypogonadism in patients with end stage renal disease. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
24
|
Mursawa H, Hatakeyama S, Yamamoto H, Tanaka Y, Soma O, Matsumoto T, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Saitoh H, Suzuki T, Narumi S, Ohyama C. Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney Transplantation. Transplant Proc 2018; 50:145-149. [PMID: 29407299 DOI: 10.1016/j.transproceed.2017.12.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Accepted: 12/05/2017] [Indexed: 11/30/2022]
Abstract
PURPOSE Pre-emptive kidney transplantation (PKT) is expected to improve graft and cardiovascular event-free survival compared with standard kidney transplantation. Aortic calcification is reported to be closely associated with renal dysfunction and cardiovascular events; however, its implication in PKT recipients remains incompletely explored. This aim of this study was to evaluate whether PKT confers a protective effect on aortic calcification, renal function, graft survival, and cardiovascular event-free survival. METHODS One hundred adult patients who underwent renal transplantation between January 1996 and March 2016 at Hirosaki University Hospital and Oyokyo Kidney Research Institute were included. Among them, 19 underwent PKT and 81 patients underwent pretransplant dialysis. We retrospectively compared pretransplant and post-transplant aortic calcification index (ACI), renal function (estimated glomerular filtration rate [eGFR]), and graft and cardiovascular event-free survivals between the 2 groups. RESULTS The median age of this cohort was 45 years. Preoperative ACI was significantly lower in PKT recipients. There were no significant differences between the 2 groups regarding postoperative eGFR, graft survival, and cardiovascular event-free survival. However, the ACI progression rate (ΔACI/y) was significantly lower in PKT recipients than in those who underwent pretransplant dialysis. Higher ACI was significantly associated with poor cardiovascular event-free survival. CONCLUSIONS PKT is beneficial in that it contributes to the slow progression of after transplantation. Although we could not observe significant differences in graft and cardiovascular event-free survivals between the 2 groups, slow progression of aortic calcification showed a potential to decrease cardiovascular events in PKT recipients during long-term follow-up.
Collapse
|
25
|
Kido K, Hatakeyama S, Hamano I, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Tomita H, Suzuki T, Narumi S, Ohyama C. Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report. Transplant Proc 2018; 50:898-901. [PMID: 29661460 DOI: 10.1016/j.transproceed.2018.01.015] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Accepted: 01/29/2018] [Indexed: 02/08/2023]
Abstract
BACKGROUND Paraganglioma (extra-adrenal pheochromocytoma) of the bladder is a very rare disease, accounting for 0.06% of all bladder tumors. Optimal management of bladder paraganglioma before kidney transplantation is unknown. We report a case of partial cystectomy for urinary bladder paraganglioma before living kidney transplantation. CASE PRESENTATION A 59-year-old man with a 27-year history of hemodialysis was referred to our department for further examination of a bladder tumor detected during pre-transplantation testing. Cystoscopy revealed a submucosal tumor on the right side of the bladder. The patient experienced a hypertensive crisis during transurethral resection of the bladder tumor. Endocrinologic and pathologic examinations confirmed the diagnosis of paraganglioma in the urinary bladder. A partial cystectomy was performed before kidney transplantation. Nine months after partial cystectomy, the patient underwent AB0-incompatible living kidney transplantation from his spouse. No disease recurrence or graft rejection was observed 12 months after the transplantation. CONCLUSIONS To our knowledge, this is the 1st report on the management of paraganglioma in the urinary bladder before living kidney transplantation. Kidney transplantation after partial cystectomy is an option that may be considered in patients with paraganglioma of the urinary bladder, with careful observations of bladder function and vesicoureteral reflux to the grafts.
Collapse
|